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ABSTRACT

GESTATIONAL WEIGHT GAIN, OFFSPRING ASTHMA AND WHEEZE
PHENOTYPES IN PROJECT VIVA

MAY 2019

KATHRYN A. WAGNER, B.A., UNIVERSITY OF MASSACHUSETTS AMHERST

M.S., UNIVERSITY OF MASSACHUSETTS AMHERST

Directed by: Professor Youssef Oulhote

In the US, 8.4% of children are diagnosed with asthma by age 18, making asthma
one of the most common chronic conditions among children. Additionally, 25% of
children experience persistent wheezing by age 6, an indicator of childhood asthma. Both
childhood asthma and persistent wheezing may be linked to inflammatory and immune
mechanisms, which are associated with inadequate and excessive gestational weight gain.
Studies investigating the relationship between gestational weight gain and offspring
asthma and wheeze phenotypes are limited by self-reported gestational weight gain, early
age at asthma and wheeze assessments, limited adjustment for potential confounders and
no trimester-specific evaluations. Therefore, we investigated the association between
total and trimester-specific gestational weight gain, offspring asthma and wheeze
phenotypes among 2128 mother-child pairs in Project Viva, a prospective cohort study in
eastern Massachusetts. Gestational weight gain was abstracted from medical records and

iii

self-reported prepregnancy weight, and defined both continuously and using Institute of
Medicine guidelines. Offspring asthma was obtained via maternal report at approximately
7 years, while wheeze trajectories were derived via latent class mixed models based on
presence of wheeze between 1 and 9 years, inclusively, via maternal report. We
investigated the relationship between gestational weight gain, offspring asthma and
wheeze phenotypes using multivariable regressions and predicted probabilities, adjusting
for important covariates. Most women had excessive gestational weight gain (56%),
while 31% had adequate gestational weight gain and 13% had inadequate gestational
weight gain. Approximately 18% of children had current mid-childhood asthma, 13% had
early transient wheeze and 13% had persistent wheeze. We found a non-linear association
between total gestational weight gain and offspring current mid-childhood asthma.
Additionally, there was a 36% decreased odds of early transient wheeze among children
of mothers with excessive third trimester gestational weight gain (aOR= 0.64; 95% CI:
0.42-0.98). This study adds to the body of literature by incorporating adequate inclusion
of confounders and risk factors for adjustment, as well as being the first study to evaluate
the association between trimester-specific gestational weight gain, offspring asthma and
wheeze phenotypes.
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CHAPTER I
BACKGROUND AND SIGNIFICANCE

A. Introduction
Asthma is a chronic lung disease that causes inflammation and narrowing of the
airways.1 This causes recurrent wheezing, chest tightness and discomfort, coughing,
shortness of breath, reduced energy and feelings of weakness or tiredness.1,2 Asthma is
usually diagnosed in childhood (<18 years) and is one of the most common chronic
conditions among children.3,4 In the United States, approximately 6.2 million children
under the age of 18, or 8.4%, have been diagnosed with asthma, with boys having higher
prevalence of childhood asthma than girls.5,28,29,30 Overall rates have been fairly
consistent over the past two decades;4,5 therefore assessing potential modifiable risk
factors for childhood asthma remains critical.
Childhood asthma has serious, long-term health consequences that can last a lifetime.
The mucus that accumulates in the lungs due to asthmatic symptoms increases the
likelihood of developing bronchitis and pneumonia.6 These conditions can further affect
the lungs by causing permanent lung scarring or damage and, in the case of pneumonia,
can lead to antibiotic resistance if repeat infections occur.6 Additionally, if asthma
symptoms are not well controlled, chronic inflammation of the airways can lead to lung
scarring and have health effects similar to chronic obstructive pulmonary disease, or
COPD.6 Uncontrolled and untreated asthma is particularly harmful and can be fatal; in
2015, 3,615 people in the United States, or 10 people per day, died from asthma.6,7
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In addition to lung health consequences, childhood asthma can cause lifestyle changes
that affect long-term health. Children who have asthma are more likely to miss school
than those who do not have asthma, and later in life this could also lead to missed work.8
Additionally, asthma is the third leading cause of hospitalization in children.8 Asthma
also causes changes to an individual’s daily lifestyle and personal choices, which can
have repercussions on personal health. Asthma, particularly exercise-induced asthma, can
cause children to develop a decreased exercise tolerance, which can lead to a sedentary
lifestyle and associated negative health effects including obesity, diabetes, and high blood
pressure.3,6 Sleep can also be affected by asthma since coughing, wheezing and shortness
of breath can all make it difficult to fall asleep and/or stay asleep.3,9
Established risk factors for developing childhood asthma include allergies, eczema,
family history of allergies, eczema and/or asthma, frequent respiratory infections, low
birth weight, second-hand smoke before and/or after birth and growing up in a lowincome, urban environment.1,2,4,5 African-Americans and Puerto Ricans are at an
increased risk for asthma than those of other racial and ethnic groups.1,4,5 Additionally,
boys have childhood asthma at a higher prevalence than girls, though this pattern
switches after puberty.28,29,30 It is important to continue to explore potential modifiable
risk factors for childhood asthma due to its large, continued prevalence in children and its
serious health and personal consequences.
Wheezing during childhood is a common ailment, characterized by a high-pitched
whistling sound made while breathing, particularly exhaling, caused by narrowed airways
or inflammation.31 While wheezing is commonly associated with asthma, it is also a
symptom of multiple other respiratory and immunologic conditions, such as respiratory
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infections, allergies and cystic fibrosis.31, 32,33 Wheezing is most often diagnosed within
the first six years of life.31 The Global Initiative for Asthma (GINA) has produced
guidelines, proposing a number of tools, including frequency, gravity and duration of
wheezing symptoms, to guide clinicians in determining whether a child’s wheezing
patterns are indicative of asthma.31 One system for wheeze classification is the timetrend, or temporal, classification which categorizes wheezing into early transient (ending
before 3 years), recurrent or persistent (starting before 3 years and persisting beyond 6
years) and late onset wheeze (starting after 3 years).35 It is estimated that by age 6, 2030% of children have recurrent or persistent wheezing and half experience at least one
episode of wheezing of any kind.31,33 Children with recurrent and persistent episodes of
wheeze have been determined by the GINA guidelines to have a higher probability of
having asthma, while early transient wheeze is more indicative of having early
respiratory infections.31,43 Properly identifying when wheezing symptoms represent
asthma is imperative for clinicians since early identification of asthma may predict longterm outcomes and improved treatment responses.31, 35
Childhood wheezing, though a symptom of multiple respiratory and immunologic
conditions, has been associated with negative health consequences in and of itself.
Childhood wheezing has been shown to decrease adulthood lung function as compared to
children with no wheezing in a recent meta-analysis.34 Additionally, childhood atopic
wheezing was found to be significantly associated with chronic obstructive pulmonary
disease (COPD) prevalence in adults in the same meta-analysis.34
In addition to health consequences, wheezing of any phenotype can be severe and
result in reduced quality of life stemming from frequent use of health care systems,
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leading to increased economic costs.31,36 Many of the health and social consequences
associated with asthma, such as sleep disturbances, limited activities, and missed school
are also applicable to childhood wheezing due to the frequent relationship between the
two.
Established risk factors associated with childhood wheezing include exposure to
environmental tobacco smoke, maternal smoking during pregnancy, breast feeding for
less than or equal to six months, having siblings, attending a day care center, personal
history of eczema or allergic rhinitis, having acid reflux, low socioeconomic status,
crowding, and allergen exposure. 37, 32, 38 Males are also more likely to experience
wheezing in childhood as compared to females.37,38,41 It is important to continue to
explore potential modifiable risk factors for childhood wheeze, particularly recurrent or
persistent wheeze, due to its association with childhood asthma and to aid clinicians in
properly identifying childhood asthma as early as possible to promote positive outcomes
and treatment responses.

B. Physiology of Exposure-Outcome Relationship
It is generally accepted that childhood asthma and persistent wheezing have roots in inutero and early life development, but the mechanisms behind this are not well
understood. Since asthma is the inflammation and subsequent narrowing of the lungs’
airways, the proposed biological mechanism between gestational weight gain and
childhood asthma and the persistent wheeze phenotype largely focus on two
inflammatory and immune mechanisms: 1) leptin (Figure 1) and 2) tumor necrosis factor
α, (TNF- α) (Figure 2). These inflammation and immune responses occur during both
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inadequate and excessive gestational weight gain, though studies have largely focused on
excessive gestational weight gain due to the current obesity epidemic in the United
States.10, 20
In terms of the first mechanism, leptin is a pro-inflammatory adipokine, a type of cellsignaling protein known as a cytokine, that is secreted from adipose tissue.10,11 Abnormal
cytokine production has been observed in obese individuals; high gestational weight gain
creates an increased adiposity in the mother’s body that may cause abnormal cytokine
production to occur. 12,13, 14, 15,39 Excessive gestational weight gain, particularly in the
second and third trimester, has been associated with higher levels of cord blood leptin.
16,17

It has been suggested that leptin has a pro-inflammatory effect on a child’s airways as

it increases airway responsiveness and exacerbates asthma and asthma symptoms, such as
wheeze.10,11,18
In terms of the second mechanism, tumor necrosis factor α (TNF-α) is another
cytokine that is involved with systemic inflammation.19 It has been shown that excessive
weight gain in pregnancy relates directly to an increased capacity of infant blood cells to
produce TNF- α, which is associated with asthma by age 9.19,20 In turn, TNF- α
production very early in life (<3 months) is predictive of childhood asthma.19
Childhood asthma and wheeze prevalence has been observed to differ between boys
and girls, with boys having a higher prevalence than girls.28,29,30,40,41 This difference
switches after puberty, where females then have a higher prevalence of asthma and
wheeze through adulthood than males.28,29,30,40 It is suggested that the overall mechanism
behind these sex differences is caused by differential physiologic morphology,
maturation, and hormonal changes that occur during puberty, but these mechanisms are
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not well understood. More specifically, some potential causes of the sex differences in
asthma and wheeze prevalence include pulmonary dysanapsis, testosterone, hormonal
changes’ influence on airway size, β2 adrenoceptor regulation, sex differences in the
antioxidant response to oxidative stress, gender-influenced genetic polymorphisms and
smooth muscle and vascular function, though it remains unclear which mechanism or
mechanisms are the likely cause.28,29,30, 40

C. Epidemiology of Exposure-Outcome Relationship
Four epidemiologic studies have addressed the relationship between gestational
weight gain and childhood asthma.10, 19-21 All four were prospective cohort studies.
Two of these studies measured gestational weight gain exclusively through selfreported post-partum questionnaire data20,21, one study used birth certificate weight,19
and one study used medical record extraction.10 Three of these studies measured
childhood asthma using parent questionnaires, 10,19,21 whereas one used self-reported data
from the child.20 Three of the studies used physician-diagnosed asthma19,20,21 and one
used active symptoms of asthma or medicine prescribed in the past year10 as the outcome
of interest. Each of these studies included children of different ages within their study
population: age 4,19 ages 9-14,20 age 7,21 and ages 2-9.10 None of the studies adjusted for
all, but some combination of, factors that have an established association between
gestational weight gain and asthma including: family history of allergy, eczema and/or
asthma, smoking during pregnancy, low-income status, and race/ethnicity. Lastly, none
of the studies have evaluated an association between trimester-specific gestational weight
gain and offspring asthma.
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Two studies found that low or inadequate total gestational weight gain was positively
associated with development of childhood asthma as compared to normal or adequate
gestational weight gain,19 though one was merely suggestive,20 whereas the other two
studies found that high or excessive total gestational weight gain was positively
associated with development of childhood asthma when compared to normal or adequate
total gestational weight gain.10,22
In the most recent prospective cohort study to date, Polinski et al. followed 6,450
children, from birth in 2001 to age 4, in the United States.19 The authors used birth
certificate data to obtain total gestational weight gain information, and if missing was
obtained via self-reported values on questionnaires.19 The presence of childhood asthma
was assessed at three time points: 9-month after birth, 2 years, and 4 years.19 At each time
point, a parent or guardian of the child was asked during an interview whether a doctor
had ever told them that their child has asthma.19 The authors found a 56% increased odds
of having a child with asthma when the mother gained less than 5 kg, as compared to
gaining 10-15 kg, after adjustment (aOR: 1.56; 95% CI: 1.04-2.35).20 This study was
limited in that it relied upon self-reported total gestational weight gain for 19% of
mothers who had missing birth certificate data. In addition, childhood asthma diagnosis
in children under 4 years of age is difficult to diagnose and therefore subject to
misclassification. Lastly, the study did not adjusted for several well-known risk factors
such as family history of allergy, eczema and/or asthma and low-income status.
Three epidemiologic studies have addressed the relationship between gestational
weight gain and offspring wheezing.21, 32,39 All three were prospective cohort studies.
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One study measured gestational weight gain through self-reported post-partum
questionnaire data,21 one study used the difference between self-reported pre-pregnancy
weight and weight in the third trimester from medical records,39 and one study provided
no information on how the gestational weight gain was measured.32 All three of these
studies measured offspring wheeze using parental questionnaires.21, 32.39 Two of the
studies used wheeze phenotypes, including early transient, persistent and late-onset, as
the outcomes of interest21,32 while one study used dichotomous wheeze as the outcome.39
Each of the three epidemiologic studies included children of different ages in their
studies: ages 1-4 years,39 18 months to 7 years,21 and 6-7 years.32 Two of the studies
adjusted for a number of factors that have an established association between gestational
weight gain and offspring wheeze including family history of allergy, eczema and/or
asthma, smoking during pregnancy, low-income status, and race/ethnicity,39,32 while one
study did not include family history of eczema and asthma, low-income status nor
race/ethnicity.21 None of the studies evaluated an association between trimester-specific
gestational weight gain and offspring wheeze.
The findings of one study was null,32 whereas one study found an increased risk of
persistent wheeze with 5-9 kg gestational weight gain, as compared to 10-15 kg
gestational weight gain,21 and one study found an increased risk of offspring wheeze at 1
year and at 4 years with increasing gestational weight gain.39
In the most recent prospective cohort study to date evaluating the relationship
between gestational weight gain and offspring wheeze, Harpsoe et al. followed 38,874
mothers and children from 1996 to 2002, in Denmark as part of the Danish National Birth
Cohort.21 The authors used maternal self-reported gestational weight gain information at
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6 months post-partum as the exposure of interest.21 Parental reported wheezing was
obtained via telephone interview at 18 months and via questionnaire at 7 years.21
Wheezing was categorized into early transient (>1 episode of wheezing from birth to 18
months), persistent (both early and current wheezing), and late onset (current but not
early wheezing).21 The authors found an increased risk of offspring persistent wheeze
among mothers who had a gestational weight gain of 5-9 kg in comparison to mothers
who had a gestational weight gain of 10-15 kg, after adjustment (aOR = 1.24, 95% CI:
1.01-1.40). This study was limited for a number of reasons. First, there was a potential
selection bias introduced since the study sample had a higher socioeconomic status than
the source population, particularly concerning since low socioeconomic status is a risk
factor for childhood wheezing. Second, the authors loosely used the temporal wheezing
phenotypes based on GINA guidelines, but used wheeze assessment at 18 months as a
proxy for the recommended 3 years. This would potentially cause misclassification of
wheezing phenotypes since wheezing information between 18 months and 3 years would
be lost and could change the classification of the wheeze phenotype present. Lastly,
Harpsoe et al. lacked adjustment for some well-known risk factors for wheezing
including family history of eczema and paternal allergy, low-income status and
race/ethnicity.
Additionally, one study evaluated if sex of the child modified the association
between gestational weight gain and offspring asthma.20 This was a prospective cohort
study which measured gestational weight gain via maternal self-report on questionnaires
and asthma status via child self-report on questionnaires given between age 9 years to 14
years.20 Sex of the child did not modify the association between gestational weight gain
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and offspring asthma.20 There have been no studies that have specifically evaluated if sex
of the child modifies the association between gestational weight gain and offspring
wheeze phenotypes, as wheezing is often considered as a symptom of asthma.

D. Summary of Significance and Innovation
In summary, the prior epidemiologic studies of gestational weight gain and offspring
asthma and wheeze phenotypes have several limitations: 1) the majority relied upon selfreported gestational weight gain, 19,20,21 2) offspring asthma was assessed among children
of an unreliable age to be diagnosed with asthma in two of four studies, 10,19 3) offspring
wheezing was assessed among children of an age where they would be unable to
determine distinct phenotypes in one of three studies,39 4) well known confounders were
inconsistently adjusted for across studies,10, 19,20,21, and 5) no prior study has evaluated the
potential association between trimester-specific gestational weight gain and offspring
asthma nor wheeze phenotypes. These limitations may explain the conflicting results of
prior epidemiologic studies. Therefore, we have prospectively studied the association
between gestational weight gain, measured at multiple time points throughout pregnancy
via medical visits, and offspring asthma and wheeze phenotypes among children age 7
years and 1 year to 9 years, respectively, using Project Viva cohort data. This study is
significant because gestational weight gain is a potentially modifiable factor and if
associated with childhood asthma and/or wheeze phenotypes, could direct new primary
prevention efforts. This study is also significant because it evaluates whether the timing
of gestational weight gain across trimesters is clinically relevant in the development of
offspring asthma and/or wheeze, which could provide directed clinical recommendations
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for prevention as well as insight into the etiology of asthma and/or wheeze phenotypes.
This study is innovative because we have access to multiple, measured points of
gestational weight gain via medical record abstraction, a 7 year follow-up period among
children to more accurately diagnose asthma and a 9 year follow-up period among
children to determine specific wheeze phenotypes, along with comprehensive information
on potential covariates. Additionally, this study is innovative because it is the first to
evaluate an association between trimester-specific gestational weight gain and offspring
asthma and wheeze phenotypes.
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CHAPTER II
SPECIFIC AIIMS AND HYPOTHESES

Specific Aim #1: To evaluate the association of gestational weight gain and offspring
risk of asthma.
Hypothesis #1a: There will be a U-shaped association between total gestational
weight gain and offspring asthma.
Hypothesis #1b: Excessive total gestational weight gain will be positively
associated with offspring asthma, as compared to adequate total gestational
weight gain.
Hypothesis #2a: Second and third trimester gestational weight gain will be
positively associated with offspring asthma.
Hypothesis #2b: Excessive trimester-specific gestational weight gain will be
associated with offspring asthma, as compared to adequate trimester-specific
gestational weight gain.
Hypothesis #3: There will be a stronger positive association between gestational
weight gain and offspring asthma among boys, as compared to girls.

Specific Aim #2: To evaluate the association of gestational weight gain and offspring
wheezing phenotypes.
Hypothesis #4a: There will be a U-shaped association between total gestational
weight gain and offspring persistent wheeze.
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Hypothesis #4b: Excessive total gestational weight gain will be positively
associated with offspring persistent wheeze, as compared to adequate total
gestational weight gain.
Hypothesis #5a: Second and third trimester gestational weight gain will be
positively associated with offspring persistent wheeze.
Hypothesis #5b: Excessive trimester-specific gestational weight gain will be
associated with offspring persistent wheeze, as compared to adequate trimesterspecific gestational weight gain.
Hypothesis #6: There will be a stronger positive association between gestational
weight gain and offspring persistent wheeze among boys, as compared to girls.
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CHAPTER III
STUDY DESIGN AND METHODS
A. Overall Strategy
We assessed the relationship between gestational weight gain and childhood
asthma and wheeze phenotypes using data from Project Viva. Project Viva is a
prospective cohort study based in Massachusetts, which enrolled mothers and now
includes their singleton children.22 A total of 2341 women were recruited at their first
prenatal visit in eastern Massachusetts between 1999 and 2002 and enrolled in the
study.22 In-person visits were conducted with mothers during pregnancy in the late first
(median 9.9 weeks of gestation) and second (median 27.9 weeks) trimesters.22 Mothers
and children were later seen in the hospital during the delivery admission and then during
infancy (median age 6.3 months), early childhood (median 3.2 years) and mid-childhood
(median 7.7 years), with in-person visits presently continuing through the children’s
teenage years.22 Prenatal visits occurred during pregnancy, from which medical records
were drawn, and annual questionnaires were mailed to mothers between in-person
visits.22 Out of the 2341 women enrolled, a total of 2128 women had a live birth and 1279
mother-child pairs provided information at the mid-childhood visit.22

B. Study Population
Eligible participants were pregnant women less than 22 weeks gestation.22
Women were excluded if they: 1) had a multiple gestation, 2) were unable to answer
questions in English, 3) had a gestational age ≥ 22 weeks at recruitment, or 4) had plans
to move away prior to delivery.22 For the purposes of this study, mothers who were
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missing information on offspring asthma status were excluded for the analysis between
gestational weight gain and offspring risk of asthma. As for the analysis between
gestational weight gain and offspring risk of wheeze phenotypes, mothers who did not
provide at least one offspring wheeze measurement from 1 year to 5 years, inclusively,
and at least one measurement from 6 years to 9 years, inclusively, were excluded from
the study.41 Due to the use of multiple imputation, women who had missing information
on exposures and/or covariates were able to be included in modeling and therefore were
not excluded from the analyses.

C. Exposure Assessment
Gestational weight gain was gathered from self-reported prepregnancy weight
data and weight measurements from prenatal visits, ending with the last prenatal visit
prior to birth via medical record abstraction. Trimester-specific gestational weight gain
was interpolated from medical record weight given during prenatal visits.
Total gestational weight gain was assessed both continuously and categorically.
Categorical gestational weight gain was divided into three groups based on the Institute
of Medicine (IOM) guidelines: inadequate, adequate and excessive weight gain.23 These
guidelines recommend varying levels of weight gain for each woman dependent on their
prepregnancy BMI.23 For women with a ‘normal’ prepregnancy BMI (18.5-24.9 kg/m2),
weight gain should fall within 11.5-16.0 kg.23 For women with an underweight
prepregnancy BMI (<18.5 kg/m2), weight gain should fall within 12.5-18.0 kg.23 For
women with an overweight prepregnancy BMI (25.0-29.9 kg/m2), weight gain should fall
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within 7.0-11.5 kg.23 For women with an obese prepregnancy BMI (≥ 30.0 kg/m2),
weight gain should fall within 5.0-9.0 kg.23
Trimester-specific gestational weight gain was also assessed both continuously
and categorically, the latter based on IOM guidelines. The Institute of Medicine assumes
a 0.5-2.0 kg weight gain in the first trimester and then varying levels of kilogram per
week weight gain across the second and third trimesters, dependent on prepregnancy
BMI.23 For women with a ‘normal’ prepregnancy BMI (18.5-24.9 kg/m2), mean weight
gain per week should be 0.45 kg (range: 0.36-0.45 kg).23 For women with an underweight
prepregnancy BMI (<18.5 kg/m2), mean weight gain per week should be 0.45 kg (range:
0.45-0.59 kg).23 For women with an overweight prepregnancy BMI (25.0-29.9 kg/m2),
mean weight gain per week should be 0.27 kg (range: 0.23-0.32 kg).23 For women with
an obese prepregnancy BMI (≥ 30.0 kg/m2), mean weight gain per week should be 0.23
kg (range: 0.18-0.27 kg).23
Self-reported prepregnancy weight has been validated in a previous Project Viva
study against clinically measured weights among 170 study participants who had weight
recorded in the medical record within 3 months prior to their last menstrual period.24 The
observed association between the self-reported and clinically measured weight was linear
with correlation coefficients of 0.99 overall and mean underreporting of weight of
approximately 1 kg or 2.2 pounds.24 Findings did not differ by race/ethnicity, gestational
age at study enrollment, or weight itself.24
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D. Outcome Assessment
Presence of childhood asthma was assessed during the mid-childhood in-person
visit, occurring at a median age of 7.7 years. During the in-person visit, mothers were
asked: “Have you ever been told by a health care professional, such as a doctor, physician
assistant or nurse practitioner, that your child has…asthma?” Mothers were additionally
asked: “Have you ever been told by a health care professional, such as a doctor, physician
assistant or nurse practitioner, that your child has…wheezing or reactive airways?” If the
mother responded to either question affirmatively then she was then asked: “In the past
12 months, has your child taken any of the following medications?” which included a
number of medications often used for asthma, wheezing and/or reactive airways. Current
mid-childhood asthma was considered to be present when a mother had reported that her
child had health care professional-diagnosed asthma and had experienced wheezing or
reactive airways and/or had taken asthma medications within the past 12 months;
otherwise the child was considered to not have current mid-childhood asthma. Therefore,
mid-childhood current asthma was assessed as a dichotomous outcome.
Mother-report of health-care-professional-diagnosed childhood asthma has been
validated in previous studies.25,26 One validation study found a high level of sensitivity
(88.5%) and specificity (95.7%) between parental report of doctor-diagnosed asthma in
their child and the general practitioner’s recorded diagnosis.25 A second validation study
found a high level of agreement between parental report of offspring early onset asthma
(<10 years of age, Cohen’s kappa 0.72) and medically-recorded diagnosis.26
Presence of childhood wheeze was assessed during annual questionnaires from 1
to 9 years inclusively. In each questionnaire, mothers were asked: “Since your child was
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[age at last questionnaire], had he/she ever had wheezing (or whistling in the chest)?”
Childhood wheeze was considered to be present when a mother had responded with a
“Yes” to this question, otherwise the child was not considered to have wheeze at that
time.
After wheezing status was determined, wheeze trajectories, or phenotypes, were
derived using latent class mixed modeling as performed by Tse et al.41 Only those
children who had at least one wheeze measurement between 1 year and 5 years and 6
years and 9 years, inclusively, were included in this modeling.41 Tse et al. specified 3
latent classes, which provided the best fit.41 Three distinct wheeze phenotypes were
identified and did not differ by sex of the child: never or infrequent wheeze, early
transient wheeze and persistent wheeze, labeled as such based on the observed temporal
pattern and patterns reported in the prior literature.41
Parental report of current wheezing during early childhood has been validated in
two studies.45, 46 Both studies found a high level of sensitivity (86%,45 82.8%46) and
specificity (91.8%,45 85%46) between parental report of their infants’ current wheezing
status and physician report.45, 46 Both validation studies assessed only short-term parental
report of wheezing and included only infants.

E. Covariate Assessment
We identified established risk factors for childhood asthma based on prior
literature.10,19,20,21 Mother’s age at enrollment, mother’s prepregnancy BMI, nulliparity,
maternal asthma, allergy and eczema, maternal smoking during pregnancy, household
income, maternal and paternal college graduate, maternal race/ethnicity, distance to the
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nearest major roadway, and age in days at the mid-childhood visit were considered a
priori confounders of the relationship between gestational weight gain and offspring
asthma and wheeze phenotypes, respectively. Additionally, paternal asthma, allergy and
eczema and maternal secondhand smoke exposure during pregnancy were considered risk
factors for offspring asthma and wheeze phenotypes, respectively. Sex of the child was
assessed as a potential effect modifier; if it did not modify the relationship between
gestational weight gain and offspring asthma nor wheeze phenotypes then it would be
included as an a priori confounder. All variables were obtained from questionnaires and
in-person visits except gestational weight gain measurements during pregnancy, which
were obtained through medical record abstraction, and distance to the nearest roadway,
which was calculated using distance to the nearest A1 or A2 road (U.S. Census Features
Class) from the home address at the time of study enrollment, as performed by Rice et
al.42
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CHAPTER IV
DATA ANALYSIS
Specific Aim #1: To evaluate the association of gestational weight gain and offspring
risk of asthma.
Specific Aim #2: To evaluate the association of gestational weight gain and offspring
wheezing phenotypes.

A. Univariate Analysis
The study population size after accounting for exclusion criteria, as numbers and
percents, is presented in Table 1. We also present the mean and standard deviation of
continuous gestational weight gain, as well as the percent distribution of categorical
gestational weight gain in Table 2. The percent distribution of observed offspring asthma
and wheeze phenotypes is presented in Table 3.

B. Bivariate Analyses
Covariate distributions were assessed against total and trimester-specific
gestational weight gain, both continuously and categorically (Table 4) and against asthma
status and wheeze phenotypes (Table 5). Continuous variables were assessed using t-tests
and Pearson’s correlation coefficients. Categorical variables were assessed using chisquare tests and analysis of variance (ANOVA). P-values from these tests are reported.
Additionally, the association between total and trimester-specific gestational
weight gain, both continuously and categorically, and current mid-childhood asthma were
modeled using unconditional logistic regression, presented in Table 6. Odds ratios and
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95% confidence intervals are reported. The association between total and trimesterspecific gestational weight gain, both continuously and categorically, and wheeze
phenotypes were modeled using unconditional multinomial logistic regression, presented
in Table 7. Adequate gestational weight gain, no current mid-childhood asthma, and
never or infrequent wheeze served as reference.
We explored potential non-linear relationships of continuous total gestational
weight gain and offspring current mid-childhood asthma using generalized additive
models (GAMs) with penalized smoothing regression splines (Figure 3), and visually
inspected plots of the smoothed data.

C. Multivariate Analyses
Multivariable logistic regression was used to evaluate the association between
gestational weight gain and offspring current mid-childhood asthma. Multinomial logistic
regression was used to evaluate the association between gestational weight gain and
offspring wheeze phenotypes. For both procedures two adjusted models were produced
and are presented in Tables 6 and 7, respectively. In the first adjusted model, all a priori
confounders were included due to their established association with both gestational
weight gain and offspring asthma and wheeze phenotypes in the prior literature. In the
second adjusted model, all a priori risk factors were included, in addition to the a priori
confounders, due to their established association with offspring asthma and wheeze in the
prior literature.
Due to how common current mid-childhood asthma and wheezing are in the
general population, we determined that the resulting odds ratios would not be a

21

reasonable approximation of the risk ratio: the statistic to be expected from a cohort
study, such as this. Therefore, we calculated risk differences for current mid-childhood
asthma (Table 6) and wheeze phenotypes (Table 7), respectively, using predicted
probabilities.
To assess whether sex of the child modified the relationship between gestational
weight gain and offspring current mid-childhood asthma, inclusion of an interaction term
into a multivariable logistic regression was used. The same procedure was performed in
order to assess whether sex of the child modified the relationship between gestational
weight gain and offspring wheeze, but through inclusion of an interaction term into a
multivariable multinomial regression.
To prevent potential bias associated with missing data, we imputed missing data
on exposures and covariates using multiple imputation by chained equations. We
specified an adequate number of iterations (n=50) according to the proportion of missing
information.46 Mean estimates and variances were computed from the 50 imputed data
sets using Rubin’s rule.47
Additionally, we performed a sensitivity analysis to ascertain if the length of
gestational age affected the estimates in comparison to the study population including all
gestational ages. We limited the analyses to include only those who had experienced a
full-term pregnancy, defined as having delivered the baby at 37 weeks gestation or later,
and compared these estimates to those among the full study cohort.
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CHAPTER V
RESULTS

Of the 2128 live births in the Project Viva cohort, we excluded 896 mother-child
pairs that did not have information on their asthma status at mid-childhood and 833
mother-child pairs that did not have an available wheeze trajectory (Table 1). This
yielded an analytic cohort of 1232 mother-child pairs for the current mid-childhood
asthma assessment and 1295 mother-child pairs for the wheeze phenotypes assessment.
Women and their partners were predominately white, college educated and had a
household income greater than $70,000 per year.
Women had a mean total gestational weight gain of 15.54 kg (SD: 5.69); 13% had
inadequate total gestational weight gain, 31% had adequate total gestational weight gain
and 56% had excessive total gestational weight gain (Table 2). Women in their first
trimester had a mean weight gain of 2.94 kg (SD: 2.87), in their second trimester had a
mean weight gain of 6.31 kg (SD: 2.49) and in their third trimester had a mean weight
gain of 6.31 kg (SD: 3.02) (Table 2). Women across all trimesters were most likely to
have had excessive gestational weight gain, though the proportion of women having
excessive weight gain decreases across the trimesters from 63% in the first trimester to
57% in the third trimester (Table 2). Current mid-childhood asthma was present in 17.8%
of children whereas 74% of children were classified as having never wheezed or had
infrequent wheeze, 13% had early transient wheeze and 13% had persistent wheeze
(Table 3).
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Women who had excessive total gestational weight gain had a higher prepregnancy BMI than inadequate and adequate total gestational weight gain, with women
who had adequate weight gain having the lowest pre-pregnancy BMI (Table 4).
Additionally, women with excessive total gestational weight gain were more likely to be
nulliparous, be a smoker during pregnancy, have a higher income, be of other or white
race/ethnicity, and have a boy, than women who had inadequate or adequate total
gestational weight gain. Women who had excessive gestational weight gain during the
first trimester were older, had a lower pre-pregnancy BMI, be a smoker during
pregnancy, have a higher income, be a college graduate, and be of white race/ethnicity,
than women who had inadequate or adequate first trimester gestational weight gain
(Table 4). Women who had excessive second trimester gestational weight gain were more
likely to be nulliparous, not have a history of asthma, be a smoker during pregnancy,
have a higher income, be a college graduate, be of Hispanic, other or white race/ethnicity,
and lived closer to a major roadway, than women who had inadequate or adequate second
trimester gestational weight gain (Table 4). Women who had excessive third trimester
gestational weight gain were younger, had a higher prepregnancy BMI, were nulliparous,
be of other race/ethnicity, and have a boy than women who had inadequate or adequate
gestational weight gain (Table 4).
Children with current mid-childhood asthma were more likely to be male and to
have younger mothers, mothers with higher pre-pregnancy BMI, maternal and paternal
history of asthma, paternal history of allergy, a mother who smoked during the
pregnancy, a household income less than $70,000, mothers and fathers who did not
graduate college, mothers and fathers of African American or Hispanic race/ethnicity,
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than children without current mid-childhood asthma (Table 5). Other covariates did not
differ significantly among participants who did and did not have current mid-childhood
asthma. Children with persistent wheeze were more likely to be male and to have
younger mothers, mothers with a higher pre-pregnancy BMI, have siblings, maternal and
paternal history of asthma, allergy and eczema, a household income less than $70,000,
mothers and fathers who did not graduate college, mothers and fathers of African
American or Hispanic race/ethnicity, and living closer to a major roadway than children
with never/infrequent or early transient wheeze (Table 5). Other covariates did not differ
significantly among participants who did and did not have persistent wheeze.
After visual inspection of the generalized additive models, we determined there
was a departure from linearity of total gestational weight gain and offspring current midchildhood asthma (Figure 3). There was no such observation among any of the three
trimester-specific gestational weight gain and offspring current mid-childhood asthma
(results not shown).
We evaluated associations between total and trimester-specific gestational weight
gain and offspring current mid-childhood asthma via logistic regression, but findings
were not statistically significant after adjustment (Table 6). In the unadjusted analyses we
observed an increased odds of offspring current mid-childhood asthma among children
whose mothers had inadequate second trimester gestational weight gain (OR=2.06; 95%
CI: 1.30-2.23), as compared to adequate second trimester gestational weight gain, though
this was attenuated after adjustment (Table 6).
We evaluated associations between total and trimester-specific gestational weight
gain and offspring wheeze phenotypes via logistic regression (Table 7). We found a 36%
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decreased odds of offspring current mid-childhood asthma among children whose mother
had excessive third trimester gestational weight gain, as compared to adequate third
trimester gestational weight gain (aOR: 0.64; 95% CI: 0.42-0.98) (Table 7).
Additionally, we evaluated associations between total and trimester-specific
gestational weight gain and offspring current mid-childhood asthma via conditional
predicted probabilities (Table 8). We found an approximately 5% increased probability of
having a child with current mid-childhood asthma among mothers who had inadequate
total and inadequate second trimester gestational weight gain, respectively, as compared
to adequate total and adequate second trimester gestational weight gain (Table 8). We
also found an approximately 3% increased probability of having a child with current midchildhood asthma among mothers who had inadequate third trimester gestational weight
gain, as compared to mothers who had adequate third trimester gestational weight gain
(Table 8).
Lastly, we evaluated associations between total and trimester-specific gestational
weight gain and offspring wheeze phenotypes via conditional predicted probabilities
(Table 9). We found an approximately 5-6% decreased probability of having a child with
early transient wheeze among mothers who had inadequate or excessive third trimester
gestational weight gain, as compared to mothers who had adequate third trimester
gestational weight gain (Table 9). We also found an approximately 2-4% decreased
probability of having a child with early transient wheeze among mothers who had
inadequate or excessive first trimester gestational weight gain, as compared to mothers
who had adequate first trimester gestational weight gain (Table 9). Additionally, we
found a 2.5% increased probability of having a child with persistent wheeze among
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mothers who had inadequate total gestational weight gain, as compared to mothers who
had adequate total gestational weight gain (Table 9).
We found that there is no effect modification by sex of the child in the association
between gestational weight gain and offspring current mid-childhood asthma nor
offspring wheeze phenotypes (results not shown). Lastly, after removing preterm
gestational age from the overall sample in a separate analysis, findings were similar
(results not shown).

27

CHAPTER VI
DISCUSSION

In this prospective cohort study, we found a non-linear association between total
gestational weight gain and offspring current mid-childhood asthma. We found increased
probabilities of offspring current mid-childhood asthma among mothers with inadequate
second trimester, third trimester and total gestational weight gain, as compared to
adequate gestational weight gain during those times. We also found a 36% decreased
odds of early transient wheeze among children whose mothers had excessive gestational
weight gain during the third trimester (aOR: 0.64; 95% CI: 0.42-0.98), as compared to
adequate third trimester gestational weight gain. Additionally, we found a suggestive
decreased odds of early transient wheeze among children whose mothers had inadequate
third trimester gestational weight gain (aOR: 0.60; 95% CI: 0.36-1.02), as compared to
adequate third trimester gestational weight gain. Lastly, we found decreased probabilities
of offspring early transient wheeze among mothers with inadequate and excessive
gestational weight gain during the first and third trimesters, as compared to adequate
gestational weight gain during those times.
Our findings for the associations between gestational weight gain and offspring
current mid-childhood asthma are consistent with some prior literature while being
inconsistent with others. Polinski et al. found a 56% increased odds of having a child
with asthma when women gained less than 5 kg, as compared to women who gained 1015 kg (aOR: 1.56; 95% CI: 1.04-2.35). Dumas et al. found a 28% increased odds of
childhood asthma when women had low gestational weight gain as compared to normal
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gestational weight gain (aOR: 1.28; 95% CI: 0.98-1.66). Additionally, Harpsoe et al.
found a 97% increased odds of current severe childhood asthma at 7 years among
mothers who had a greater than or equal to 25 kg total gestational weight gain as
compared to mothers who had a 10-15 kg total gestational weight gain. Our findings
suggest that there are increased probabilities of offspring current mid-childhood asthma
among children whose mothers had inadequate gestational weight gain during the second
trimester, third trimester and overall.
Our finding of a non-linear association between total gestational weight gain and
offspring current mid-childhood asthma is consistent with Harpsoe et al. Harpsoe et al.
found U-shaped associations between total gestational weight gain and offspring ever
having asthma and offspring having previous asthma. Our findings suggest a U-shaped
association between total gestational weight gain and offspring current mid-childhood
asthma.
Our findings for the associations between gestational weight gain and offspring
wheeze phenotypes are inconsistent with prior literature. Leermakers et al. found a 9%
increased odds of wheezing from 1 to 4 years with continuous gestational weight gain,
per standard deviation increase in weight gain (aOR: 1.09; 95% CI: 1.04-1.14). Harpsoe
et al. found a 24% increased odds of persistent wheeze among children whose mothers
had 5-9 kg gestational weight gain, as compared to mother with 10-15 kg gestational
weight gain (aOR: 1.24; 95% CI: 1.01-1.40). Rusconi et al. found no association between
wheeze phenotypes and inadequate or excessive total gestational weight gain, as
compared to adequate total gestational weight gain. We found a 36% decreased odds of
early transient wheeze among children whose mothers had excessive third trimester
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gestational weight gain (aOR: 0.64; 95% CI: 0.42-0.98) and, suggestively, inadequate
third trimester gestational weight gain (aOR: 0.60; 95% CI: 0.36-1.02), as compared to
adequate third trimester gestational weight gain. We also found decreased probabilities of
early transient wheeze among children whose mothers had inadequate or excessive first
or third trimester gestational weight gain, as compared to adequate first or third trimester
gestational weight gain.
Differences in study findings may be due to smaller sample size in our study and
failure of prior studies to have complete adjustment for potential confounders. Previous
studies have oftentimes not adjusted for a number of important risk factors including, but
not limited to: parental history of asthma, allergy and/or eczema, maternal smoking
during pregnancy, low-income status and maternal race/ethnicity. Our study adjusted for
all of these important risk factors and a multitude of others. Additionally, study
populations vary widely between studies with much of the prior literature having been
conducted outside of the United States.
This study has several strengths. First, this was the first study to evaluate the
relationship between gestational weight gain and offspring wheeze phenotypes, an
informative symptomatic pattern used to clinically diagnose childhood asthma. Second,
we measured gestational weight gain using medical records, offspring asthma at
approximately 7 years and offspring wheeze phenotypes until 9 years. These
measurements increase validity of both the exposure and outcome assessments since
medically recorded weight gain is the gold standard and both asthma and wheezing
should be measured through childhood in order to obtain the most accurate diagnoses and
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identification. Lastly, we adjusted for all a priori confounders and risk factors based on
prior literature and direct acyclic graphs (DAGs).
Total gestational weight gain was calculated by taking the difference between
self-reported prepregnancy weight and medical record weight at the last prenatal visit
before delivery. There is the possibility that self-reported prepregnancy weight was
incorrectly reported. This would cause either an overestimation or underestimation of
total gestational weight gain depending on whether women overstated or understated
their prepregnancy weight, due to conscious misreport or rounding. If women
misreported their prepregnancy weight this would lead to an underestimate of the true
odds ratio (OR), though self-reported prepregnancy weight has been validated against
clinically measured weights in a previous Project Viva study.24 It seems likely that there
is some misclassification of total gestational weight gain due to misreporting of
prepregnancy weight, but we expect that the impact of this misreporting is minimal since
it has been adequately validated in this study population and was further minimized when
evaluating gestational weight gain categorically based on the IOM guidelines.
Offspring current mid-childhood asthma status was determined via maternal
report at the Mid-Childhood Visit, which occurred at a mean child age of 7.7 years. Due
to the nature of parental reporting and the accuracy of asthma diagnoses, it is possible
that there is misclassification of offspring asthma. This means that some mothers will
report that a doctor had told them their child has asthma when in actuality they do not,
and vice versa. However, validation studies on parental reporting of childhood asthma
have found a high level of agreement between parental, particularly maternal, report of
doctor-diagnosed asthma in their child and the general practitioner’s recorded

31

diagnosis.25,26 Additionally, we held current mid-childhood asthma to a stringent criterion
in order to minimize the possibility of misdiagnosis by physician. Mothers needed to
report that their child had doctor-diagnosed asthma plus had wheezing symptoms in the
past 12 months and/or were taking asthma medications within the past 12 months. Based
on this stringent criterion, it seems less likely that misclassification of current midchildhood asthma would occur. If mothers misreported their child’s asthma status or the
child had a misdiagnosis of asthma and met the other criterion, then this would lead to an
underestimation of the true OR. It seems possible that there is misclassification of
offspring asthma status but we expect that the impact is modest and will be minimized by
the combination of validated maternal report of doctor-diagnosed offspring asthma and
strict current mid-childhood asthma criterion.
Offspring wheezing was determined via maternal report on yearly questionnaires
between ages 1 year and 9 years inclusively and then offspring wheeze phenotypes were
derived using latent class mixed models. There is the possibility of non-differential
misclassification of wheeze phenotypes due to the nature of parental reporting of
symptoms and the latent class mixed models categorization procedure. This means that
some mothers may have reported their child as having not wheezed in the past year when
in actuality they had, or vice versa. However, validation studies on parental report of
current wheeze symptoms have found a high agreement between parental report and
doctor-recognized wheeze symptoms. If mothers misreported their child’s wheezing
symptoms then this would lead to an underestimation of the true OR. It seems possible
that there is misclassification of offspring wheeze status, which was later used to derive
wheeze trajectories, but we expect the impact of this to be minimal since wheeze status
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was later categorized into latent classes of wheeze trajectories and multiple wheeze
statuses were used in these derivations, therefore misclassification would be minimized.
Additionally, by utilizing latent classes in order to categorize wheeze phenotypes there is
the potential for the latent class procedure to have misclassified observations into
inaccurate wheeze phenotypes. This would have lead to an underestimation of the true
OR. It is likely that some misclassification of wheeze phenotypes occurred during the
latent class mixed models procedure.
A limitation of the study was the large loss to follow-up. At the Mid-Childhood
in-person visit, 58% (N=1232) of women from the original study sample (N=2128)
provided information about asthma status in their child. With regard to the wheeze
trajectories, 61% (N=1295) of women from the original study sample had provided
sufficient information about their child’s wheezing status across 1 to 5 years and 6 to 9
years.
Selection bias in this study may have occurred through differential loss to followup. For example, mothers who had either inadequate or excessive gestational weight gain
and a child who was diagnosed with asthma may drop out of the study at a higher rate
than other mother-child pairs. This specific situation could be caused by either overall
poor health of the mother and/or child or low socioeconomic status, which could limit the
access to resources or transportation needed to continue participation in the study,
particularly attending the Mid-Childhood Visit where asthma assessment took place. If
these mother-child pairs were lost from the study, this would bias the OR towards the
null. This scenario seems likely given the large loss to follow-up in the study,
particularly during the in-person visits.
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In order to limit the affect of loss to follow-up, we utilized multiple imputation.
Through this method we were able to include mother-child pairs in the analyses who
originally had missing information on exposures and/or covariates. These mother-child
pairs with missing information on these factors would have otherwise been excluded
from the analyses, if not for the use of multiple imputation. This increased our sample
size, in comparison to a complete case analysis, and therefore increased the power of this
study, maximizing all participant information considering our relatively small sample
size.
In this prospective cohort study, information on offspring asthma was not
collected differentially for those with different gestational weight gain. Therefore, there
should be no information bias because asthma questions within the questionnaires and inperson visits were a small subset of all questions asked. In addition, it would be highly
unlikely that women would misreport their child’s asthma status differentially based on
their gestational weight gain years prior.
Data on possible confounders and risk factors were gathered using numerous
questionnaires, in-person visits and medical records. Additionally, our study had
adequate power to include all a priori confounders and risk factors in our models.
However, it is possible that a confounder not suggested by the literature may be missed or
that the collection of data for the confounder left residual confounding. For example, if
maternal dietary patterns were positively associated with gestational weight gain and
positively associated with offspring asthma and was not controlled for in statistical
models, the reported OR would be an overestimation of the true effect of gestational
weight gain on offspring asthma. The impact of unmeasured confounders such as dietary
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factors could be moderate, but thorough evaluation of prior literature for potential
confounders and risk factors has been done and therefore it is unlikely there are major
confounders or risk factors missing from our analyses.
We also accounted for the potential for residual confounding in our study by
attempting to include multiple confounders and risk factors as proxies for a broader, or
difficult to measure, confounder or risk factor. For example, low socioeconomic status
has been associated with both gestational weight gain and offspring asthma and wheezing
but this is difficult to measure. Therefore, we used a combination of parental college
graduate status, household income, maternal race/ethnicity and others as measures of
socioeconomic status. The impact of residual confounding could still be moderate, but
thorough inclusion of multiple confounders and risk factors in our analyses should limit
these effects.
The Project Viva cohort may have limited generalizability to other US
populations. The cohort is largely white and college educated, with a most having a
yearly household income over the national average in the years that information was
collected.48 Additionally, participants resided exclusively in the greater Boston area and
had health insurance.22
Additionally, here are differences in the etiology of childhood asthma and
persistent wheezing in comparison to adult or late-onset asthma and wheezing, therefore
these results are not generalizable to adults who develop asthma or wheezing.27 However,
these results should be generalizable to other, diverse populations of mother-child pairs
since the inflammatory and immune responses of leptin and tumor necrosis factor-α occur
consistently across populations and therefore affect youth in the same way.
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Table 1. Number and Percent in Study Sample; Project Viva
Original Study Sample (Number of Live Births)

2128

Asthma Status at Mid-Childhood

1232 (58%)

Wheeze Trajectories Available

1295 (61%)
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Table 2. Distribution of Total and Trimester-Specific Gestational Weight Gain
among Participants with Current Mid-Childhood Asthma and with Wheeze
Phenotypes;
Project
Viva
Table 2. Distribution
of Total and
Trimester-Specific Gestational Weight Gain among Participants with Current Mid-Childhood
Asthma and with Wheeze Phenotypes; Project Viva
Current Mid-Childhood Asthma
N(%)
M (SD)
Range
15.41 (5.37) (-7.27 - 33.18)

Total Gestational Weight Gain (kg)
Total Gestational Weight Gain
Inadequate
Adequate
Excessive

156 (12.68%)
395 (32.03%)
681 (55.29%)

Trimester-Specific Gestational Weight Gain (kg)
1st Trimester
2nd Trimester
3rd Trimester

2.81 (2.76) (-8.98 - 17.96)
6.32 (2.39) (-10.55 - 14.48)
6.28 (2.90) (-10.03 - 17.55)

Trimester-Specific Gestational Weight Gain
1st Trimester - Inadequate
1st Trimester - Adequate
1st Trimester - Excessive

189 (15.39%)
269 (21.81%)
774 (62.80%)

2nd Trimester - Inadequate
2nd Trimester - Adequate
2nd Trimester - Excessive

146 (11.86%)
343 (27.80%)
743 (60.34%)

3rd Trimester - Inadequate
3rd Trimester - Adequate
3rd Trimester - Excessive

251 (20.40%)
273 (22.17%)
708 (57.43%)
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Table 2 (continued). Distribution of Total and Trimester-Specific Gestational
Weight Gain among Participants with Current Mid-Childhood Asthma and with
Wheeze
Phenotypes;
Table 2 (continued).
DistributionProject
of Total andViva
Trimester-Specific Gestational Weight Gain among Participants with Current MidChildhood Asthma and with Wheeze Phenotypes; Project Viva
N(%)
Total Gestational Weight Gain (kg)

Wheeze Phenotypes
M (SD)
Range
15.45 (5.32) (-7.27 - 33.18)

Total Gestational Weight Gain
Inadequate
Adequate
Excessive

165 (12.75%)
411 (31.76%)
719 (55.49%)

Trimester-Specific Gestational Weight Gain (kg)
1st Trimester
2nd Trimester
3rd Trimester

2.79 (2.67) (-8.98 - 17.96)
6.38 (2.39) (-10.55 - 15.66)
6.29 (2.90) (-10.03 - 17.29)

Trimester-Specific Gestational Weight Gain
1st Trimester - Inadequate
1st Trimester - Adequate
1st Trimester - Excessive

204 (15.71%)
278 (21.49%)
813 (62.80%)

2nd Trimester - Inadequate
2nd Trimester - Adequate
2nd Trimester - Excessive

152 (11.71%)
345 (26.68%)
798 (61.61%)

3rd Trimester - Inadequate
3rd Trimester - Adequate
3rd Trimester - Excessive

266 (20.55%)
286 (22.12%)
743 (57.33%)
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Table 3. Distribution of Current Asthma at Mid-Childhood and Wheeze
Phenotypes; Project Viva
N

Percent

Current Mid-Childhood Asthma (N=1232)
No current childhood asthma
Yes, current childhood asthma

1013
219

82.22%
17.78%

Wheeze Phenotypes (N=1295)
Never/infrequent wheeze
Early transient wheeze
Persistent wheeze

960
165
170

74.13%
12.74%
13.13%
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Table 4. Distribution of Covariates According to Total and Trimester-Specific
Gestational Weight Gain; Project Viva
Table 4. Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
Continuous
Total
Mother's Age at Enrollment; Mean (SD)

-0.05

p-value
0.17

Total
Inadequate
N = 156
31.90 (5.74)

Total
Adequate
N = 395
32.52 (5.37)

Total
Excessive
N = 681
32.04 (5.04)

p-value
0.27

Mother's Pre-Pregnancy BMI; Mean (SD)

-0.26

<0.0001

24.37 (6.17)

23.34 (4.71)

25.61 (5.11)

<0.0001

No (N=1111) 14.70 (5.26)
Yes (N=1017) 16.18 (5.38)

<0.0001

168 (15.12%)
115 (11.31%)

343 (30.87%)
306 (30.09%)

600 (54.01%)
596 (58.60%)

0.02

No (N=1842) 15.54 (5.27)
Yes (N=286) 14.49 (5.96)

0.03

245 (13.30%)
38 (13.29%)

557 (30.24%)
92 (32.17%)

1040 (56.46%)
156 (54.55%)

0.74

No (N=1884) 15.53 (5.25)
Yes (N=244) 14.54 (6.13)

0.04

241 (12.79%)
42 (17.21%)

578 (30.68%)
71 (29.10%)

1065 (56.53%)
131 (53.69%)

0.18

No (N = 1524) 15.57 (5.42)
Yes (N=604) 15.02 (5.23)

0.10

194 (12.73%)
89 (14.74%)

464 (30.45%)
185 (30.63%)

866 (56.82%)
330 (54.64%)

0.37

No (N = 1582) 15.48 (5.36)
Yes (N=546) 15.22 (5.40)

0.47

212 (13.40%)
71 (13.00%)

484 (30.59%)
165 (30.22%)

886 (56.01%)
310 (56.78%)

0.84

No (N = 1855) 15.40 (5.32)
Yes (N=273) 15.47 (5.67)

0.87

245 (13.21%)
38 (13.92%)

567 (30.57%)
82 (30.04%)

1043 (56.23%)
153 (56.04%)

0.88

No (N = 2006) 15.50 (5.32)
Yes (N = 122) 14.00 (5.84)

0.02

263 (13.11%)
20 (16.39%)

613 (30.56%)
36 (29.51%)

1130 (56.33%)
66 (54.10%)

0.53

Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 15.26 (5.26)
Former (N = 401) 15.64 (5.21)
Smoker (N = 270) 16.09 (6.38)

0.22

208 (14.28%)
49 (12.22%)
26 (9.63%)

476 (32.67%)
111 (27.68%)
62 (22.96%)

773 (53.05%)
241 (60.10%)
182 (67.41%)

0.0009

15.46 (5.27)
15.34 (5.75)
14.79 (6.06)
15.52 (6.24)
14.29 (5.93)

0.75

239 (13.57%)
35 (13.26%)
4 (7.84%)
0 (0.00%)
4 (14.29%)

538 (30.55%)
80 (30.30%)
14 (27.45%)
3 (23.08%)
11 (39.29%)

984 (55.88%)
149 (56.44%)
33 (64.71%)
10 (76.92%)
13 (46.43%)

0.46

<= $70,000 (N = 893) 15.09 (5.88)
>$70,000 (N = 1235) 15.62 (5.00)

0.10

139 (15.57%)
144 (11.66%)

253 (28.33%)
396 (32.06%)

501 (56.10%)
695 (56.28%)

0.09

No (N = 754) 14.97 (6.24)
Yes (N = 1374) 15.61 (4.92)

0.06

115 (15.25%)
168 (12.23%)

210 (27.85%)
439 (31.95%)

429 (56.90%)
767 (55.82%)

0.23

No (N = 825) 15.18 (6.16)
Yes (N = 1303) 15.54 (4.88)

0.28

120 (14.55%)
163 (12.51%)

213 (25.82%)
436 (33.46%)

492 (59.64%)
704 (54.03%)

0.09

14.63 (4.15)
14.35 (5.92)
14.80 (6.21)
16.17 (6.36)
15.71 (5.13)

0.0097

21 (17.21%)
57 (16.10%)
26 (16.56%)
11 (13.10%)
168 (11.91%)

51 (41.80%)
110 (31.07%)
51 (32.48%)
18 (21.43%)
419 (29.70%)

50 (40.98%)
187 (52.82%)
80 (50.96%)
55 (65.48%)
824 (58.40%)

0.002

0.03

0.15

6.69 (1.28)

6.71 (1.37)

6.84 (1.34)

0.21

0.0013

128 (11.68%)
155 (15.02%)

329 (30.02%)
320 (31.01%)

639 (58.30%)
557 (53.97%)

0.03

0.67

2934.16 (321.42)

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paternal History of Asthma; N(%)

Maternal History of Allergy; N(%)

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761)
2 hr/wk (N = 264)
3 hr/wk (N = 51)
4 hr/wk (N = 13)
5 hr/wk (N = 28)
Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)
Asian (N = 122)
Black (N = 354)
Hispanic (N = 157)
Other (N = 84)
White (N = 1411)
Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male (N = 1096) 15.91 (5.30)
Female (N = 1032) 14.92 (5.39)
Age of Child at Mid-Childhood Visit (Days); Mean (SD)

-0.02
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2885.67 (292.82) 2885.85 (282.92)

0.16

Table 4 (continued). Distribution of Covariates According to Total and TrimesterSpecific Gestational Weight Gain; Project Viva
Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
1st Trimester
Continuous

2nd Trimester
Continuous

3rd Trimester
Continuous

Mother's Age at Enrollment; Mean (SD)

0.07

p-value
0.01

-0.02

p-value
0.77

-0.15

p-value
<0.0001

Mother's Pre-Pregnancy BMI; Mean (SD)

-0.6

0.26

-0.37

<0.0001

-0.13

<0.0001

No (N=1111)
Yes (N=1017)

2.80 (2.84)
2.83 (2.67)

0.86

6.09 (2.35)
6.56 (2.40)

0.0006

5.81 (2.84)
6.79 (2.87)

<0.0001

No (N=1842)
Yes (N=286)

2.80 (2.69)
2.92 (3.26)

0.60

6.41 (2.33)
5.67 (2.64)

0.0003

6.33 (2.85)
5.91 (3.20)

0.10

No (N=1884)
Yes (N=244)

2.86 (2.67)
2.49 (3.35)

0.14

6.36 (2.35)
6.04 (2.61)

0.15

6.32 (2.90)
6.00 (2.87)

0.23

No (N = 1524)
Yes (N=604)

2.83 (2.87)
2.77 (2.49)

0.72

6.39 (2.36)
6.15 (2.44)

0.11

6.35 (2.92)
6.10 (2.82)

0.17

No (N = 1582)
Yes (N=546)

2.94 (2.71)
2.45 (2.88)

0.0083

6.30 (2.47)
6.36 (2.14)

0.70

6.24 (2.96)
6.41 (2.70)

0.38

No (N = 1855)
Yes (N=273)

2.83 (2.77)
2.71 (2.72)

0.64

6.31 (2.39)
6.41 (2.36)

0.62

6.27 (2.88)
6.35 (3.02)

0.75

No (N = 2006)
Yes (N = 122)

2.83 (2.76)
2.57 (2.88)

0.46

6.34 (2.34)
5.99 (3.00)

0.24

6.34 (2.86)
5.44 (3.31)

0.01

Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457)
Former (N = 401)
Smoker (N = 270)

2.75 (2.78)
2.77 (2.45)
3.35 (3.14)

0.09

6.30 (2.31)
6.46 (2.37)
6.15 (2.92)

0.48

6.21 (2.74)
6.40 (3.19)
6.59 (3.35)

0.3

0.41

6.30 (2.83)
6.32 (3.07)
5.73 (3.72)
5.28 (2.54)
6.25 (3.32)

0.67

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paternal History of Asthma; N(%)

Maternal History of Allergy; N(%)

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761)
2 hr/wk (N = 264)
3 hr/wk (N = 51)
4 hr/wk (N = 13)
5 hr/wk (N = 28)

2.78 (2.69)
2.96 (2.69)
3.02 (4.53)
4.25 (2.55)
2.22 (2.63)

0.47

6.38 (2.32)
6.07 (2.49)
6.04 (3.27)
5.99 (2.64)
5.82 (3.04)

<= $70,000 (N = 893)
>$70,000 (N = 1235)

2.95 (3.26)
2.72 (2.39)

0.17

6.01 (2.67)
6.52 (2.16)

0.0006

6.12 (2.97)
6.38 (2.84)

0.14

No (N = 754)
Yes (N = 1374)

2.92 (3.31)
2.76 (2.48)

0.35

5.97 (2.85)
6.47 (2.14)

0.0008

6.08 (3.21)
6.37 (2.74)

0.10

No (N = 825)
Yes (N = 1303)

2.97 (3.35)
2.73 (2.38)

0.17

5.99 (2.80)
6.50 (2.11)

0.0005

6.23 (3.12)
6.31 (2.77)

0.62

Asian (N = 122)
Black (N = 354)
Hispanic (N = 157)
Other (N = 84)
White (N = 1411)

2.61 (2.37)
2.93 (3.71)
2.90 (3.04)
3.47 (4.07)
2.75 (2.39)

0.36

6.33 (1.69)
5.53 (2.96)
5.96 (2.57)
6.30 (2.41)
6.53 (2.23)

<0.0001

5.69 (2.47)
5.89 (3.19)
5.94 (3.11)
6.40 (2.94)
6.43 (2.82)

0.05

-0.05

0.22

0.05

0.02

0.04

0.05

2.95 (2.94)
2.67 (2.56)

0.08

6.49 (2.41)
6.15 (2.36)

0.02

6.47 (2.96)
6.09 (2.81)

0.02

0.03

0.14

-0.05

0.15

-0.04

0.32

Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)

Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male (N = 1096)
Female (N = 1032)
Age of Child at Mid-Childhood Visit (Days); Mean (SD)
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Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
1st Trimester
Inadequate

1st Trimester
Adequate

1st Trimester
Excessive

Mother's Age at Enrollment; Mean (SD)

30.39 (5.91)

31.95 (4.62)

32.69 (5.17)

p-value
<0.0001

Mother's Pre-Pregnancy BMI; Mean (SD)

26.72 (6.21)

24.22 (5.02)

24.41 (4.93)

<0.0001

No (N=1111) 173 (15.57%)
Yes (N=1017) 163 (16.03%)

229 (20.61%)
207 (20.35%)

709 (63.82%)
647 (63.62%)

0.89

No (N=1842) 279 (15.15%)
Yes (N=286) 57 (19.86%)

385 (20.91%)
51 (17.77%)

1177 (63.93%)
179 (62.37%)

0.13

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paternal History of Asthma; N(%)
No (N=1884)
Yes (N=244)

284 (15.07%)
52 (21.31%)

390 (20.70%)
46 (18.85%)

1210 (64.23%)
146 (59.84%)

0.05

Maternal History of Allergy; N(%)
No (N = 1524) 241 (15.81%)
Yes (N=604) 95 (15.73%)

325 (21.33%)
111 (18.38%)

958 (62.86%)
398 (65.89%)

0.32

No (N = 1582) 245 (15.50%)
Yes (N=546) 92 (16.82%)

322 (20.37%)
113 (20.66%)

1014 (64.14%)
342 (62.52%)

0.63

No (N = 1855) 292 (15.74%)
Yes (N=273) 44 (16.12%)

373 (20.11%)
63 (23.08%)

1190 (64.15%)
166 (60.81%)

0.48

No (N = 2006) 320 (15.95%)
Yes (N = 122) 17 (13.93%)

402 (20.04%)
34 (27.87%)

1284 (64.01%)
71 (58.20%)

0.31

Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 238 (16.32%)
Former (N = 401) 61 (15.21%)
Smoker (N = 270) 38 (14.13%)

318 (21.81%)
80 (19.95%)
37 (13.75%)

902 (61.87%)
260 (64.84%)
194 (72.12%)

0.06

277 (15.73%)
44 (16.67%)
9 (17.65%)
0 (0.00%)
5 (17.86%)

366 (20.78%)
51 (19.32%)
11 (21.57%)
3 (23.08%)
3 (10.71%)

1118 (63.49%)
169 (64.02%)
31 (60.78%)
10 (76.92%)
20 (71.43%)

0.67

<= $70,000 (N = 893) 180 (20.16%)
>$70,000 (N = 1235) 156 (12.63%)

161 (18.03%)
275 (22.27%)

552 (61.81%)
804 (65.10%)

0.0006

No (N = 754) 155 (20.56%)
Yes (N = 1374) 181 (13.17%)

140 (18.57%)
296 (21.54%)

459 (60.88%)
897 (65.28%)

0.0002

No (N = 825) 166 (20.10%)
Yes (N = 1303) 171 (13.13%)

154 (18.64%)
282 (21.66%)

506 (61.26%)
849 (65.21%)

0.0007

21 (17.21%)
75 (21.25%)
36 (22.93%)
16 (19.05%)
189 (13.39%)

27 (22.13%)
53 (15.01%)
33 (21.02%)
14 (16.67%)
308 (21.81%)

74 (60.66%)
225 (63.74%)
88 (56.05%)
54 (64.29%)
915 (64.80%)

0.004

6.76 (1.27)

6.94 (1.24)

6.73 (1.39)

0.08

210 (19.16%)
225 (21.80%)

716 (65.33%)
640 (62.02%)

0.24

2878.71 (285.78)

2896.99 (298.81)

0.67

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761)
2 hr/wk (N = 264)
3 hr/wk (N = 51)
4 hr/wk (N = 13)
5 hr/wk (N = 28)
Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)
Asian (N = 122)
Black (N = 354)
Hispanic (N = 157)
Other (N = 84)
White (N = 1411)
Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male (N = 1096) 170 (15.51%)
Female (N = 1032) 167 (16.18%)
Age of Child at Mid-Childhood Visit (Days); Mean (SD)

2889.96 (268.80)
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Table 4 (continued). Distribution of Covariates According to Total and TrimesterSpecific Gestational Weight Gain; Project Viva
Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
2nd Trimester
Inadequate

2nd Trimester
Adequate

2nd Trimester
Excessive

Mother's Age at Enrollment; Mean (SD)

31.87 (6.15)

32.52 (5.07)

32.09 (5.11)

p-value
0.33

Mother's Pre-Pregnancy BMI; Mean (SD)

26.51 (7.62)

22.96 (4.12)

25.17 (4.85)

<0.0001

No (N=1111) 180 (16.20%)
Yes (N=1017) 100 (9.83%)

296 (26.64%)
276 (27.14%)

635 (57.16%)
641 (63.03%)

<0.0001

No (N=1842) 225 (12.22%)
Yes (N=286) 55 (19.16%)

500 (27.16%)
72 (25.09%)

1116 (60.62%)
160 (55.75%)

0.01

No (N=1884) 250 (13.27%)
Yes (N=244) 30 (12.30%)

498 (26.43%)
75 (30.74%)

1136 (60.30%)
139 (56.97%)

0.46

No (N = 1524) 189 (12.40%)
Yes (N=604) 91 (15.07%)

401 (26.31%)
171 (28.31%)

934 (61.29%)
342 (56.62%)

0.07

No (N = 1582) 222 (14.04%)
Yes (N=546) 58 (10.60%)

411 (26.00%)
161 (29.43%)

948 (59.962%)
328 (59.96%)

0.17

No (N = 1855) 252 (13.58%)
Yes (N=273) 28 (10.26%)

491 (26.47%)
81 (29.67%)

1112 (59.95%)
164 (60.07%)

0.30

No (N = 2006) 265 (13.21%)
Yes (N = 122) 14 (11.48%)

535 (26.67%)
38 (31.15%)

1206 (60.07%)
70 (57.38%)

0.65

Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 202 (13.85%)
Former (N = 401) 37 (9.23%)
Smoker (N = 270) 42 (15.61%)

404 (27.71%)
111 (27.68%)
56 (20.82%)

852 (58.44%)
253 (63.09%)
171 (63.57%)

0.02

217 (12.32%)
44 (16.67%)
6 (11.76%)
3 (23.08%)
7 (25.00%)

483 (27.43%)
63 (23.86%)
13 (25.49%)
2 (15.38%)
10 (35.71%)

1061 (60.25%)
157 (59.47%)
32 (62.75%)
8 (61.54%)
11 (39.29%)

0.09

<= $70,000 (N = 893) 142 (15.90%)
>$70,000 (N = 1235) 138 (11.17%)

236 (26.43%)
337 (27.29%)

515 (57.67%)
760 (61.54%)

0.01

No (N = 754) 130 (17.24%)
Yes (N = 1374) 150 (10.92%)

179 (23.74%)
393 (28.60%)

445 (59.02%)
831 (60.48%)

0.01

No (N = 825) 130 (15.74%)
Yes (N = 1303) 150 (11.52%)

198 (23.97%)
374 (28.73%)

498 (60.29%)
778 (59.75%)

0.09

21 (17.21%)
76 (21.53%)
25 (15.92%)
10 (11.90%)
149 (10.55%)

33 (27.05%)
88 (24.93%)
35 (22.29%)
19 (22.62%)
396 (28.05%)

68 (55.74%)
189 (53.54%)
97 (61.78%)
55 (65.48%)
867 (61.40%)

<0.0001

6.58 (1.50)

6.73 (1.33)

6.84 (1.31)

0.08

284 (27.52%)
288 (27.91%)

681 (62.147%)
595 (57.66%)

0.06

2881.43 (277.65)

2890.27 (283.49)

0.40

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paternal History of Asthma; N(%)

Maternal History of Allergy; N(%)

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761)
2 hr/wk (N = 264)
3 hr/wk (N = 51)
4 hr/wk (N = 13)
5 hr/wk (N = 28)
Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)
Asian (N = 122)
Black (N = 354)
Hispanic (N = 157)
Other (N = 84)
White (N = 1411)
Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male (N = 1096) 131 (11.95%)
Female (N = 1032) 149 (14.44%)
Age of Child at Mid-Childhood Visit (Days); Mean (SD)

2919.99 (350.19)
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Table 4 (continued). Distribution of Covariates According to Total and TrimesterSpecific Gestational Weight Gain; Project Viva
Table 4 (continued). Distribution of Covariates According to Total and Trimester-Specific Gestational Weight Gain; Project Viva
3rd Trimester
Inadequate

3rd Trimester
Adequate

3rd Trimester
Excessive

Mother's Age at Enrollment; Mean (SD)

33.00 (5.32)

32.92 (4.95)

31.60 (5.24)

p-value
<0.0001

Mother's Pre-Pregnancy BMI; Mean (SD)

23.92 (5.62)

22.90 (4.28)

25.72 (5.19)

<0.0001

No (N=1111) 277 (24.93%)
Yes (N=1017) 177 (17.40%)

248 (22.32%)
223 (21.93%)

586 (52.75%)
617 (60.67%)

<0.0001

No (N=1842) 390 (21.18%)
Yes (N=286) 64 (22.30%)

414 (22.49%)
57 (19.86%)

1037 (56.33%)
166 (57.84%)

0.67

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paternal History of Asthma; N(%)
No (N=1884)
Yes (N=244)

402 (21.34%)
52 (21.31%)

412 (21.87%)
59 (24.18%)

1070 (56.79%)
133 (54.51%)

0.69

Maternal History of Allergy; N(%)
No (N = 1524) 311 (20.41%)
Yes (N=604) 143 (23.68%)

336 (22.05%)
135 (22.35%)

877 (57.55%)
326 (53.97%)

0.15

No (N = 1582) 362 (22.90%)
Yes (N=546) 92 (16.82%)

339 (21.44%)
132 (24.13%)

880 (55.66%)
323 (59.04%)

0.02

No (N = 1855) 398 (21.46%)
Yes (N=273) 57 (20.88%)

412 (22.21%)
59 (21.61%)

1045 (56.33%)
157 (57.51%)

0.83

No (N = 2006) 423 (21.09%)
Yes (N = 122) 32 (26.23%)

446 (22.23%)
24 (19.67%)

1137 (56.68%)
66 (54.10%)

0.40

Maternal Smoker Status during Pregnancy; N(%)
Never (N = 1457) 320 (21.95%)
Former (N = 401) 83 (20.70%)
Smoker (N = 270) 51 (18.96%)

336 (23.05%)
84 (20.95%)
51 (18.96%)

802 (55.01%)
234 (58.35%)
167 (62.08%)

0.22

364 (20.67%)
57 (21.59%)
15 (29.41%)
3 (23.08%)
10 (35.71%)

391 (22.20%)
64 (24.24%)
7 (13.73%)
3 (23.08%)
5 (17.86%)

1006 (57.13%)
143 (54.17%)
29 (56.86%)
7 (53.85%)
13 (46.43%)

0.26

<= $70,000 (N = 893) 201 (22.51%)
>$70,000 (N = 1235) 253 (20.49%)

179 (20.04%)
292 (23.64%)

513 (57.45%)
690 (55.87%)

0.38

No (N = 754) 174 (23.08%)
Yes (N = 1374) 281 (20.45%)

150 (19.89%)
321 (23.36%)

430 (57.03%)
772 (56.19%)

0.30

No (N = 825) 189 (22.88%)
Yes (N = 1303) 265 (20.35%)

156 (18.89%)
315 (24.19%)

481 (58.23%)
722 (55.45%)

0.28

34 (27.87%)
89 (25.21%)
38 (24.20%)
16 (19.05%)
276 (19.55%)

35 (28.69%)
67 (18.98%)
30 (19.11%)
15 (17.86%)
325 (23.02%)

53 (43.44%)
197 (55.81%)
89 (56.69%)
53 (63.10%)
811 (57.44%)

0.01

6.75 (1.29)

6.68 (1.42)

6.82 (1.33)

0.33

220 (20.07%)
251 (24.32%)

649 (59.22%)
554 (53.68%)

0.03

2844.24 (267.98)

2886.04 (280.32)

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Secondhand Smoke Exposure; N(%)
1 hr/wk (N = 1761)
2 hr/wk (N = 264)
3 hr/wk (N = 51)
4 hr/wk (N = 13)
5 hr/wk (N = 28)
Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)
Asian (N = 122)
Black (N = 354)
Hispanic (N = 157)
Other (N = 84)
White (N = 1411)
Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male (N = 1096) 227 (20.71%)
Female (N = 1032) 227 (22.00%)
Age of Child at Mid-Childhood Visit (Days); Mean (SD)

2959.80 (331.95)
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Table 5. Distribution of Covariates According to Offspring Current Mid-Childhood
Asthma and Wheeze Phenotypes; Project Viva
Table 5. Distribution of Covariates According to Offspring Current Mid-Childhood Asthma and Wheeze Phenotype; Project Viva
No Current MidChildhood Asthma
N=1013

Current MidChildhood Asthma
N=219

Mother's Age at Enrollment; Mean (SD)

32.35 (5.13)

31.36 (5.66)

p-value
0.01

Mother's Pre-Pregnancy BMI; Mean (SD)

24.47 (4.92)

25.92 (6.39)

0.001

No
Yes

514 (80.56%)
499 (84.01%)

124 (19.44%)
95 (15.99%)

0.12

No
Yes

913 (84.54%)
100 (65.79%)

167 (15.46%)
52 (34.21%)

<0.0001

No
Yes

913 (84.15%)
100 (68.03%)

172 (15.85%)
47 (31.97%)

<0.0001

No
Yes

731 (83.26%)
282 (79.66%)

147 (16.74%)
72 (20.34%)

0.14

No
Yes

763 (84.31%)
250 (76.45%)

142 (15.69%)
77 (23.55%)

0.003

No
Yes

887 (82.67%)
126 (79.25%)

186 (17.33%)
33 (20.75%)

0.36

No
Yes

950 (82.18%)
63 (82.89%)

206 (17.82%)
13 (17.11%)

0.80

Never
Fomer
Smoker

714 (81.60%)
211 (87.92%)
88 (75.21%)

161 (18.40%)
29 (12.08%)
29 (24.79%)

0.02

1
2
3
4
5

hr/wk
hr/wk
hr/wk
hr/wk
hr/wk

852 (82.88%)
121 (79.08%)
26 (83.87%)
3 (60.00%)
9 (64.29%)

176 (17.12%)
31 (20.92%)
5 (16.13%)
2 (40.00%)
5 (35.71%)

0.24

<= $70,000
>$70,000

368 (75.88%)
645 (86.35%)

117 (24.12%)
102 (13.65%)

<0.0001

No
Yes

289 (76.46%)
724 (84.78%)

89 (23.54%)
130 (15.22%)

0.0004

No
Yes

329 (75.98%)
684 (85.61%)

104 (24.02%)
115 (14.39%)

<0.0001

Asian
Black
Hispanic
Other
White

55 (88.71%)
130 (68.78%)
46 (60.53%)
44 (80.00%)
738 (86.82%)

7 (11.29%)
59 (31.22%)
30 (39.47%)
11 (20.00%)
112 (13.18%)

<0.0001

6.79 (1.33)

6.71 (1.40)

0.44

494 (79.94%)
519 (84.53%)

124 (20.06%)
95 (15.47%)

0.04

2888.58 (285.16)

2907.37 (319.11)

0.40

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paernal History of Asthma; N(%)

Maternal History of Allergy; N(%)

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Smoker Status during Pregnancy; N(%)

Maternal Secondhand Smoke Exposure; N(%)

Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)

Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male
Female
Age of Child at Mid-Childhood Visit (Days); Mean (SD)
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Table 5 (continued). Distribution of Covariates According to Offspring Current
Mid-Childhood Asthma and Wheeze Phenotypes; Project Viva
Table 5 (continued). Distribution of Covariates According to Offspring Current Mid-Childhood Asthma and Wheeze Phenotype; Project Viva
Never/Inconsistent
Wheeze
N=960

Early Transient
Wheeze
N=165

Persistent
Wheeze
N=170

Mother's Age at Enrollment; Mean (SD)

32.53 (5.01)

32.30 (4.77)

31.29 (5.63)

p-value
0.01

Mother's Pre-Pregnancy BMI; Mean (SD)

24.52 (5.02)

24.11 (4.84)

25.96 (6.59)

0.002

No
Yes

475 (70.90%)
485 (77.60%)

93 (13.88%)
72 (11.52%)

102 (15.22%)
68 (10.88%)

0.01

No
Yes

865 (76.62%)
95 (57.23%)

129 (11.43%)
36 (21.69%)

135 (11.96%)
35 (21.08%)

<0.0001

No
Yes

865 (75.94%)
95 (60.90%)

146 (12.82%)
19 (12.18%)

128 (11.24%)
42 (26.92%)

<0.0001

No
Yes

687 (76.08%)
273 (69.64%)

105 (11.63%)
60 (15.31%)

111 (12.29%)
59 (15.05%)

0.05

No
Yes

728 (76.55%)
232 (67.44%)

117 (12.30%)
48 (13.95%)

106 (11.15%)
64 (18.60%)

0.001

No
Yes

850 (75.29%)
110 (66.27%)

139 (12.31%)
26 (15.66%)

140 (12.40%)
30 (18.07%)

0.03

No
Yes

911 (74.92%)
49 (62.03%)

149 (12.25%)
16 (20.25%)

156 (12.83%)
14 (17.72%)

0.03

Never
Fomer
Smoker

687 (75.41%)
185 (70.61%)
88 (72.13%)

110 (12.07%)
42 (16.03%)
13 (10.66%)

114 (12.51%)
35 (13.34%)
21 (17.21%)

0.22

1 hr/wk
2 hr/wk
3 hr/wk
4 hr/wk
5 hr/wk

816 (74.52%)
110 (72.37%)
20 (71.43%)
5 (83.33%)
8 (57.14%)

138 (12.60%)
21 (13.82%)
5 (17.86%)
0 (0.00%)
2 (14.29%)

141 (12.88%)
21 (13.82%)
3 (10.71%)
1 (16.67%)
4 (28.57%)

0.53

<= $70,000
>$70,000

335 (68.65%)
625 (77.45%)

68 (13.93%)
97 (12.02%)

85 (17.42%)
85 (10.53%)

0.0007

No
Yes

256 (68.82%)
704 (76.27%)

50 (13.44%)
115 (12.46%)

66 (17.74%)
104 (11.27%)

0.004

No
Yes

295 (68.45%)
665 (76.97%)

62 (14.39%)
103 (11.92%)

74 (17.17%)
96 (11.11%)

0.003

Asian
Black
Hispanic
Other
White

51 (78.46%)
114 (68.67%)
44 (56.41%)
39 (72.22%)
712 (76.39%)

8 (12.31%)
16 (9.64%)
13 (16.67%)
8 (14.81%)
120 (12.88%)

6 (9.23%)
36 (21.67%)
21 (26.92%)
7 (12.96%)
100 (10.73%)

0.001

6.79 (1.33)

6.98 (1.26)

6.59 (1.48)

0.0006

463 (69.62%)
497 (78.89%)

101 (15.19%)
64 (10.16%)

101 (15.19%)
69 (10.95%)

0.0006

2874.53 (283.77)

2881.13 (272.70)

2873.67 (292.06)

0.88

Nulliparous; N(%)

Maternal History of Asthma; N(%)

Paernal History of Asthma; N(%)

Maternal History of Allergy; N(%)

Paternal History of Allergy; N(%)

Maternal History of Eczema; N(%)

Paternal History of Eczema; N(%)

Maternal Smoker Status during Pregnancy; N(%)

Maternal Secondhand Smoke Exposure; N(%)

Household Income; N(%)

Maternal College Graduate Status; N(%)

Paternal College Graduate Status; N(%)

Maternal Race/Ethnicity; N(%)

Distance to Major Roadway at Enrollment; Mean (SD)
Sex of the Child; N(%)
Male
Female
Age of Child at Mid-Childhood Visit (Days); Mean (SD)
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Table 6. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for
Total and Trimester-Specific Gestational Weight Gain and Offspring Current MidChildhood Asthma; Project Viva

Table 6. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Gestational Weight Gain and Current Mid-Childhood Asthma; Project
Viva
Current Mid-Childhood Asthma
Unadjusted

Adjusted*

Adjusted**

RR
0.96

95% CI
0.94 - 0.99

RR
0.98

95% CI
0.95 - 1.01

RR
0.98

95% CI
0.95 - 1.01

1.57
0.88

1.01 - 2.46
0.63 - 1.23

0.64
1.21

0.40 - 1.02
0.85 - 1.73

0.81
1.09

0.63 - 1.03
0.91 - 1.31

Total First Trimester-Specific
Gestational Weight Gain

1.00

0.94 - 1.05

0.98

0.93 - 1.04

0.99

0.94 - 1.05

Total Second Trimester-Specific
Gestational Weight Gain

0.90

0.85 - 0.95

0.95

0.89 - 1.02

0.95

0.89 - 1.02

Total Third Trimester-Specific
Gestational Weight Gain

0.95

0.90 - 1.00

0.97

0.92 - 1.02

0.97

0.91 - 1.02

Inadequate vs. Adequate
Excessive vs. Adequate

1.15
0.86

0.72 - 1.83
0.60 - 1.24

1.08
1.25

0.66 - 1.78
0.85 - 1.84

1.10
1.12

0.85 - 1.42
0.92 - 1.37

Inadequate vs. Adequate
Excessive vs. Adequate

2.06
0.97

1.30 - 3.29
0.69 - 1.38

0.66
1.15

0.40 - 1.10
0.79 - 1.67

0.79
1.04

0.61 - 1.03
0.86 - 1.26

Inadequate vs. Adequate
Excessive vs. Adequate

1.43
1.09

0.91 - 2.23
0.74 - 1.59

0.80
1.09

0.50 - 1.28
0.72 - 1.65

0.86
1.03

0.67 - 1.09
0.83 - 1.27

Total Gestational Weight Gain

Categorical Total Gestational Weight Gain
Inadequate vs. Adequate
Excessive vs. Adequate

Categorical First Trimester-Specific
Gestational Weight Gain

Categorical Second Trimester-Specific
Gestational Weight Gain

Categorical Third Trimester-Specific
Gestational Weight Gain

*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy, maternal eczema,
maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, maternal
race/ethnicity, distance to a major roadway, sex of the child, and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy,
maternal eczema, maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate,
maternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at Mid-Childhood Visit, paternal asthma, paternal allergy,
paternal eczema, maternal secondhand smoking status during pregnancy
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Table 7. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for
Total and Trimester-Specific Gestational Weight Gain and Offspring Wheeze
Phenotypes; Project Viva
Table 7. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Gestational Weight Gain and Wheeze Phenotypes; Project Viva
Wheeze Phenotypes
Adjusted*

Unadjusted

Adjusted**

OR

95% CI

RR

95% CI

RR

95% CI

Early Transient Wheeze
Persistent Wheeze

0.99
0.96

0.96 - 1.02
0.93 - 0.99

0.99
0.97

0.95 - 1.02
0.94 - 1.01

0.99
0.98

0.95 - 1.02
0.95 - 1.01

Inadequate vs. Adequate Early Transient Wheeze
Excessive vs. Adequate Early Transient Wheeze

1.10
1.02

0.64 - 1.92
0.71 - 1.48

1.16
1.06

0.65 - 2.04
0.72 - 1.57

1.16
1.08

0.65 - 2.06
0.72 - 1.60

Inadequate vs. Adequate Persistent Wheeze
Excessive vs. Adequate Persistent Wheeze

1.44
0.88

0.87 - 2.38
0.61 - 1.28

1.35
0.83

0.80 - 2.29
0.56 - 1.23

1.33
0.86

0.78 - 2.29
0.57 - 1.28

Early Transient Wheeze
Persistent Wheeze

1.01
0.95

0.95 - 1.08
0.89 - 1.01

1.01
0.96

0.95 - 1.08
0.90 - 1.02

1.02
0.96

0.95 - 1.09
0.91 - 1.03

Early Transient Wheeze
Persistent Wheeze

0.98
0.92

0.92 - 1.05
0.86 - 0.99

0.97
0.97

0.89 - 1.05
0.90 - 1.05

0.96
0.98

0.89 - 1.05
0.91 - 1.06

Early Transient Wheeze
Persistent Wheeze

0.97
0.96

0.92 - 1.03
0.91 - 1.02

0.97
0.98

0.91 - 1.03
0.92 - 1.04

0.97
0.98

0.91 - 1.03
0.92 - 1.04

Inadequate vs. Adequate Early Transient Wheeze
Excessive vs. Adequate Early Transient Wheeze

0.72
0.80

0.41 - 1.27
0.54 - 1.19

0.67
0.79

0.37 - 1.20
0.53 - 1.20

0.66
0.80

0.37 - 1.19
0.53 - 1.21

Inadequate vs. Adequate Persistent Wheeze
Excessive vs. Adequate Persistent Wheeze

1.14
0.80

0.68 - 1.89
0.53 - 1.20

0.82
0.75

0.48 - 1.41
0.49 - 1.15

0.78
0.76

0.44 - 1.34
0.50 - 1.18

Inadequate vs. Adequate Early Transient Wheeze
Excessive vs. Adequate Early Transient Wheeze

0.89
1.02

0.48 - 1.66
0.69 - 1.49

0.95
1.04

0.50 - 1.80
0.69 - 1.54

1.00
1.06

0.52 - 1.92
0.71 - 1.59

Inadequate vs. Adequate Persistent Wheeze
Excessive vs. Adequate Persistent Wheeze

1.73
1.09

1.01 - 2.94
0.74 - 1.62

1.32
1.00

0.74 - 2.36
0.66 - 1.51

1.39
1.04

0.77 - 2.52
0.68 - 1.59

Inadequate vs. Adequate Early Transient Wheeze
Excessive vs. Adequate Early Transient Wheeze

0.72
0.71

0.44 - 1.18
0.48 - 1.05

0.61
0.64

0.37 - 1.02
0.61 - 1.52

0.60
0.64

0.36 - 1.02
0.42 - 0.98

Inadequate vs. Adequate Persistent Wheeze
Excessive vs. Adequate Persistent Wheeze

1.34
1.19

0.80 - 2.23
0.77 - 1.83

1.13
0.96

0.66 - 1.93
0.61 - 1.52

1.14
0.97

0.66 - 1.97
0.61 - 1.55

Total Gestational Weight Gain

Categorical Total Gestational Weight Gain

Total First Trimester-Specific
Gestational Weight Gain

Total Second Trimester-Specific
Gestational Weight Gain

Total Third Trimester-Specific
Gestational Weight Gain

Categorical First Trimester-Specific
Gestational Weight Gain

Categorical Second Trimester-Specific
Gestational Weight Gain

Categorical Third Trimester-Specific
Gestational Weight Gain

*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy, maternal eczema,
maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal race/ethnicity,
distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma, maternal allergy,
maternal eczema, maternal smoking status during pregnancy, household income above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity,
paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal
secondhand smoking status during pregnancy
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Table 8. Conditional Predicted Probabilities for Total and Trimester-Specific
Gestational Weight Gain and Offspring Current Mid-Childhood Asthma; Project
Viva
Table 8. Conditional Predicted Probabilities for Total and Trimester-Specific Gestational Weight Gain and Offspring
Current Mid-Childhood Asthma; Project Viva
Conditional Conditional
Predicted
Predicted
Probability* Probability**
%
%
1 kg
17.87%
13.10%
10 kg
14.91%
11.10%
30 kg
9.78%
7.60%

Total Gestational Weight Gain

Categorical Total Gestational Weight Gain
Inadequate
Adequate
Excessive

20.31%
13.95%
11.81%

15.22%
10.45%
8.93%

Total First Trimester-Specific Gestational Weight Gain

0.07 kg
2.94 kg
5.81 kg

13.81%
13.26%
12.72%

10.21%
9.97%
9.72%

Total Second Trimester-Specific Gestational Weight Gain

3.82 kg
6.31 kg
8.80 kg

15.04%
13.50%
12.09%

15.04%
13.50%
12.09%

Total Third Trimester-Specific Gestational Weight Gain

3.29 kg
6.31 kg
9.33 kg

14.58%
13.38%
12.28%

14.58%
13.38%
12.28%

Inadequate
Adequate
Excessive

14.15%
15.12%
12.43%

9.80%
11.60%
9.41%

Inadequate
Adequate
Excessive

19.78%
14.02%
12.42%

15.26%
10.11%
9.35%

Categorical First Trimester-Specific Gestational Weight Gain

Categorical Second Trimester-Specific Gestational Weight Gain

Categorical Third Trimester-Specific Gestational Weight Gain
Inadequate
16.47%
12.90%
Adequate
13.58%
9.82%
Excessive
12.58%
9.36%
*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal asthma,
maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income above $70,000,
maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal race/ethnicity, distance to a
major roadway, sex of the child and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity,
maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal race/ethnicity,
distance to a major roadway, sex of the child, age in days of child at Mid-Childhood Visit, paternal asthma, paternal
allergy, paternal eczema, maternal secondhand smoke exposure during pregnancy

49

Table 9. Conditional Predicted Probabilities for Total and Trimester-Specific
Gestational
Weight
GainProbabilities
and Offspring
Phenotypes;
ProjectWeight
VivaGain and
Table 9. Conditional
Predicted
for TotalWheeze
and Trimester-Specific
Gestational
Offspring Wheeze Phenotypes; Project Viva
Conditional
Predicted
Probability*
%

Conditional
Predicted
Probabilities**
%

Total Gestational Weight Gain
Never/Infrequent

1 kg
10 kg
30 kg

69.73%
73.53%
80.65%

75.71%
78.35%
83.37%

Early Transient

1 kg
10 kg
30 kg

14.12%
13.03%
10.63%

13.25%
12.22%
10.07%

Persistent

1 kg
10 kg
30 kg

16.16%
13.45%
8.72%

11.04%
9.43%
6.56%

Never/Infrequent

Inadequate
Adequate
Excessive

70.88%
75.40%
76.51%

76.32%
79.98%
80.38%

Early Transient

Inadequate
Adequate
Excessive

12.71%
11.70%
12.63%

12.12%
10.94%
11.82%

Persistent

Inadequate
Adequate
Excessive

16.40%
12.90%
10.85%

11.55%
9.08%
7.80%

Categorical Total Gestational Weight Gain

*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal
asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal
race/ethnicity, distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI,
nulliparity, maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy,
household income above $70,000, maternal college graduate, paternal college graduate, maternal
race/ethnicity, paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at
Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal secondhand smoke
exposure during pregnancy
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Table 9 (continued). Conditional Predicted Probabilities for Total and TrimesterSpecific
Gestational
Weight
GainProbabilities
and Offspring
Wheeze
Phenotypes;
ProjectWeight
Viva
Table 9 (continued).
Conditional
Predicted
for Total
and Trimester-Specific
Gestational
Gain and Offspring Wheeze Phenotypes; Project Viva
Conditional
Predicted
Probability*
%

Conditional
Predicted
Probabilities**
%

0.07 kg
2.94 kg
5.81 kg

74.89%
75.83%
76.63%

79.64%
79.96%
80.19%

Early Transient

0.07 kg
2.94 kg
5.81 kg

11.93%
12.45%
12.98%

11.11%
11.66%
12.23%

Persistent

0.07 kg
2.94 kg
5.81 kg

13.18%
11.71%
10.39%

9.25%
8.38%
7.59%

3.82 kg
6.31 kg
8.80 kg

74.03%
75.51%
76.93%

78.51%
79.76%
80.95%

Early Transient

3.82 kg
6.31 kg
8.80 kg

13.26%
12.41%
11.61%

12.56%
11.65%
10.80%

Persistent

3.82 kg
6.31 kg
8.80 kg

12.71%
12.07%
11.46%

8.93%
8.58%
8.25%

3.29 kg
6.31 kg
9.33 kg

73.88%
75.56%
77.15%

78.43%
79.79%
81.09%

Early Transient

3.29 kg
6.31 kg
9.33 kg

13.49%
12.40%
11.38%

12.58%
11.63%
10.73%

Persistent

3.29 kg
6.31 kg
9.33 kg

12.63%
12.04%
11.46%

8.99%
8.58%
8.18%

Total First Trimester Gestational Weight Gain
Never/Infrequent

Total Second Trimester Gestational Weight Gain
Never/Infrequent

Total Third Trimester Gestational Weight Gain
Never/Infrequent

*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal
asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal
race/ethnicity, distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI,
nulliparity, maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy,
household income above $70,000, maternal college graduate, paternal college graduate, maternal
race/ethnicity, paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at
Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal secondhand smoke
exposure during pregnancy
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Table 9 (continued). Conditional Predicted Probabilities for Total and TrimesterSpecific
Gestational
Weight
GainProbabilities
and Offspring
Wheeze
Phenotypes;
ProjectWeight
Viva
Table 9 (continued).
Conditional
Predicted
for Total
and Trimester-Specific
Gestational
Gain and Offspring Wheeze Phenotypes; Project Viva
Conditional
Predicted
Probability*
%

Conditional
Predicted
Probabilities**
%

Inadequate
Adequate
Excessive

74.80%
75.40%
75.94%

82.20%
76.56%
80.65%

Early Transient

Inadequate
Adequate
Excessive

11.89%
12.23%
12.56%

9.57%
13.47%
11.31%

Persistent

Inadequate
Adequate
Excessive

13.31%
12.38%
11.49%

8.22%
9.97%
8.04%

Inadequate
Adequate
Excessive

74.41%
75.19%
75.84%

79.18%
79.63%
79.99%

Early Transient

Inadequate
Adequate
Excessive

11.43%
12.04%
12.65%

10.86%
11.33%
11.81%

Persistent

Inadequate
Adequate
Excessive

14.15%
12.77%
11.51%

9.96%
9.04%
8.20%

Inadequate
Adequate
Excessive

75.57%
71.71%
76.63%

80.15%
75.99%
80.74%

Early Transient

Inadequate
Adequate
Excessive

10.85%
16.84%
11.59%

10.12%
15.92%
10.91%

Persistent

Inadequate
Adequate
Excessive

13.58%
11.45%
11.78%

9.73%
8.09%
8.36%

Categorical First Trimester Gestational Weight Gain
Never/Infrequent

Categorical Second Trimester Gestational Weight Gain
Never/Infrequent

Categorical Third Trimester Gestational Weight Gain
Never/Infrequent

*Adjusted for confounders: mother's age at enrollment, mother's pre-pregnancy BMI, nulliparity, maternal
asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy, household income
above $70,000, maternal college graduate, paternal college graduate, maternal race/ethnicity, paternal
race/ethnicity, distance to a major roadway, sex of the child and age in days of child at Mid-Childhood Visit
**Adjusted for confounders and risk factors: mother's age at enrollment, mother's pre-pregnancy BMI,
nulliparity, maternal asthma, maternal allergy, maternal eczema, maternal smoking status during pregnancy,
household income above $70,000, maternal college graduate, paternal college graduate, maternal
race/ethnicity, paternal race/ethnicity, distance to a major roadway, sex of the child, age in days of child at
Mid-Childhood Visit, paternal asthma, paternal allergy, paternal eczema, maternal secondhand smoke
exposure during pregnancy
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Figure 1. Physiologic Mechanisms #1: Leptin
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Figure 2. Physiologic Mechanism #2: Tumor Necrosis Factor – α
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Figure 3. Generalized Additive Model of Continuous Total Gestational Weight Gain

Offspring Current Mid-Childhood Asthma

and Offspring Current Mid-Childhood Asthma; Project Viva
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